However, its effect on death was very small and of borderline significance, i.e., lower risk for death before kidney failure but higher risk after kidney failure when compared to no RAS blockade.
1
—
—
However, its effect on death was very small and of borderline significance, i.e., lower risk for death before kidney failure but higher risk after kidney failure when compared to no RAS blockade.